Creative Medical Technology Holdings, Inc. (CELZ) Dividend Safety
- Dividend payout ratio · 12 months: Value (m); Formula and calculation Cash dividends paid / net income. Period ending 2026-06-30..
Dividend safety
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Dividend payout ratio · 12 months | (m) | Cash dividends paid / net income. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Dividend payments · 12 months | (m) | |
| Net income · 12 months | -6.04M USD | Net Income (Loss) Attributable to Parent |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Dividend payments · 12 months (USD) | Net income · 12 months (USD) | Dividend payout |
|---|---|---|---|
| 2026-06-30 | (m) | $-6.04M | (m) |
| 2026-03-31 | (m) | $-5.76M | (m) |
| 2025-12-31 | (m) | $-6.00M | (m) |
| 2025-09-30 | (m) | $-5.96M | (m) |
| 2025-06-30 | (m) | $-5.77M | (m) |
| 2025-03-31 | (m) | $-6.09M | (m) |
| 2024-12-31 | (m) | $-5.49M | (m) |
| 2024-09-30 | (m) | $-5.32M | (m) |
| 2024-06-30 | (m) | $-5.73M | (m) |
| 2024-03-31 | (m) | $-5.28M | (m) |
| 2023-12-31 | (m) | $-5.29M | (m) |
| 2023-09-30 | (m) | $-9.82M | (m) |
| 2023-06-30 | (m) | $-9.35M | (m) |
| 2023-03-31 | (m) | $-10.04M | (m) |
| 2022-12-31 | (m) | $-10.14M | (m) |
| 2022-09-30 | (m) | $-7.80M | (m) |
| 2022-06-30 | (m) | $-8.67M | (m) |
| 2022-03-31 | (m) | $-9.78M | (m) |
| 2021-12-31 | (m) | $19.21M | (m) |
| 2021-09-30 | (m) | $-15.53M | (m) |
| 2021-06-30 | (m) | $-13.29M | (m) |
| 2021-03-31 | (m) | $-12.23M | (m) |
| 2020-12-31 | (m) | $-36.33M | (m) |
| 2020-09-30 | (m) | $-2.90M | (m) |
| 2020-06-30 | (m) | $-5.70M | (m) |
| 2020-03-31 | (m) | $-3.94M | (m) |
| 2019-12-31 | (m) | $-8.48M | (m) |
| 2019-09-30 | (m) | $-1.36M | (m) |
| 2019-06-30 | (m) | $-522.27K | (m) |
| 2019-03-31 | (m) | $-6.87M | (m) |
| 2018-12-31 | (m) | $-13.66M | (m) |
| 2018-09-30 | (m) | $-17.07M | (m) |
| 2018-06-30 | (m) | $-15.55M | (m) |
| 2018-03-31 | (m) | $-10.00M | (m) |
| 2017-12-31 | (m) | $-2.66M | (m) |
| 2017-09-30 | (m) | $-1.38M | (m) |
| 2017-06-30 | (m) | $-1.54M | (m) |
| 2017-03-31 | (m) | $-861.58K | (m) |
| 2016-12-31 | (m) | $-766.07K | (m) |
| 2016-09-30 | (m) | $-580.53K | (m) |
| 2016-06-30 | (m) | $-372.31K | (m) |
| 2016-03-31 | (m) | $-26.63K | (m) |
| 2015-12-31 | (m) | $-30.76K | (m) |
| 2015-09-30 | (m) | $-28.34K | (m) |
| 2015-06-30 | (m) | $-27.80K | (m) |
| 2015-03-31 | (m) | $-27.27K | (m) |
| 2014-12-31 | (m) | $-28.01K | (m) |
| 2014-09-30 | (m) | $-27.56K | (m) |
| 2014-06-30 | (m) | $-27.25K | (m) |
| 2014-03-31 | (m) | $-27.25K | (m) |
| 2013-12-31 | (m) | $-27.28K | (m) |
| 2013-09-30 | (m) | $-27.23K | (m) |
| 2013-06-30 | (m) | $-27.28K | (m) |
| 2013-03-31 | (m) | $-26.58K | (m) |
| 2012-12-31 | (m) | $-25.59K | (m) |
| 2012-09-30 | (m) | $-26.39K | (m) |
| 2012-06-30 | (m) | $-25.49K | (m) |
| 2012-03-31 | (m) | $-24.93K | (m) |
| 2011-12-31 | (m) | $-24.05K | (m) |
| 2011-09-30 | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) |
| 2010-12-31 | (m) | $-17.26K | (m) |
| 2010-09-30 | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |